International COVID 19 200 mn Covid vaccine doses pledged for 'equitable' use

200 mn Covid vaccine doses pledged for ‘equitable’ use

There has been great concern about fair access to Covid-19 vaccines as rich countries have bought up billions of doses long before a jab has even been approved.

Author

Date

Category

- Advertisement -

Drugmakers Sanofi and GSK said Wednesday they would set aside 200 million doses of a future coronavirus vaccine for a global initiative to ensure equitable distribution, including in poor countries.

There has been great concern about fair access to Covid-19 vaccines as rich countries have bought up billions of doses long before a jab has even been approved.

Several dozen vaccine candidates are in clinical trials and ten are in the most advanced “phase 3” stage involving tens of thousands of volunteers.

The French and British drug giants said they had signed a statement of intent with the Gavi alliance, which administers the Covax plan for fair vaccine distribution.

- Advertisement -

“Both companies intend to contribute to Covax’s ambition to ensure successful Covid-19 vaccines reach those in need, whoever they are and wherever they live, once they obtain appropriate approvals,” a statement said.

On Sunday, the World Health Organization warned against “vaccine nationalism” and underlined that global protection can only be attained with widespread vaccination.

More than 180 countries and economies have signed up to the Covax plan, which seeks to “equitably allocate and deliver” two billion doses of Covid-19 vaccines by the end of 2021.

Last month, Gavi said 200 million vaccine doses had been secured for delivery to poor countries.

It had also signed up with AstraZeneca for access to another 300 million doses of its candidate vaccine, but those would be made available to all participants in Covax, not just poorer countries.

“Gavi is seeking to secure doses of the most promising vaccine candidates -– so that the 184 participants involved in the Covax Facility can make sure their most at-risk groups … have rapid access to doses of a safe and effective vaccine,” the initiative’s CEO Seth Berkley said.

“That is the world’s best chance to end the acute stage of this pandemic, and we encourage other vaccine manufacturers to work with us towards that shared global goal.”

Sanofi and GSK said they hope to start Phase 3 trials before the end of the year.

If successful, they plan to seek regulatory approval from the first half of 2021.

In the meantime, the companies said they are scaling up manufacturing of the vaccine’s antigen and adjuvant component parts.

According to Oxfam a group of wealthy nations representing just 13 percent of the global population have already bought up more than half of the doses of future Covid-19 vaccines.

kd/mlr/bp

© 1994-2020 Agence France-Presse
/AFP

Please follow and like us:
Tweet
Share
No tags for this post.
- Advertisement -

K Shanmugam: In Singapore, the right to speak freely goes with the duty to act responsibly

Singapore—Speaking at the 16th Religious Rehabilitation Group Seminar at Khadijah Mosque on Monday (Nov 24), K Shanmugam, the Minister for Law and Home Affairs, said that the threat of terrorism has not gone away though its “shape and nature” have changed. Citing...

Parliament receives 61 NMP proposal forms from the general public, groups

The Office of the Clerk of Parliament said yesterday (24 Nov) that Parliament has received 61 Nominated Member of Parliament (NMP) proposal forms. This is higher than the 48, 41 and 36 proposal forms that Parliament received in 2018, 2016 and...

No state acknowledgement for former President Yusof Ishak on his 50th death anniversary

Although 23 November 2020 marked half a century since Singapore's first President Yusof Ishak passed away, there was no state acknowledgement to commemorate the former President's 50th death anniversary. Neither current President Halimah Yacob, Prime Minister Lee Hsien Loong nor any other...
Please follow and like us:
Tweet
Share
No tags for this post.
Follow Me
Tweet